Rajesh C. Shrotriya

2017

In 2017, Rajesh C. Shrotriya earned a total compensation of $8.9M as Former Chairman and Chief Executive Officer at Spectrum Pharmaceuticals, a 222% increase compared to previous year.

Compensation breakdown

Bonus$863,316
Option Awards$686,601
Salary$905,625
Stock Awards$1,322,297
Other$5,111,103
Total$8,888,942

Shrotriya received $5.1M in other compensation, accounting for 57% of the total pay in 2017.

Shrotriya also received $863.3K in bonus, $686.6K in option awards, $905.6K in salary and $1.3M in stock awards.

Rankings

In 2017, Rajesh C. Shrotriya's compensation ranked 777th out of 14,666 executives tracked by ExecPay. In other words, Shrotriya earned more than 94.7% of executives.

ClassificationRankingPercentile
All
777
out of 14,666
95th
Division
Manufacturing
259
out of 5,770
96th
Major group
Chemicals And Allied Products
62
out of 2,074
97th
Industry group
Drugs
43
out of 1,730
98th
Industry
Pharmaceutical Preparations
36
out of 1,329
97th
Source: SEC filing on May 7, 2018.

Shrotriya's colleagues

We found three more compensation records of executives who worked with Rajesh C. Shrotriya at Spectrum Pharmaceuticals in 2017.

2017

Joseph Turgeon

Spectrum Pharmaceuticals

Chief Executive Officer

2017

Kurt Gustafson

Spectrum Pharmaceuticals

Chief Financial Officer

2017

Thomas Riga

Spectrum Pharmaceuticals

Chief Operating Officer

You may also like